III抗HIV治療の基礎知識

文献

  1. Mellors JW, Rinaldo CR, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-70. 1996.
  2. Rodriguez B, Sethi AK, Cheruvu VK, et al. Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA 296:1498-506. 2006.
  3. CDC; Cases of HIV Infection and AIDS in the United States and Dependent Areas, 2007. (https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-report-2007-vol-19.pdf)
  4. Gras L, Jurriaans S, Bakker M, et al. Viral load levels measured at set-point have risen over the last decade of the HIV epidemic in the Netherlands. PLoS One 4:e7365. 2009.
  5. Crum-Cianflone N, Eberly L, Zhang Y, et al. Is HIV becoming more virulent? Initial CD4 cell counts among HIV seroconverters during the course of the HIV epidemic: 1985-2007. Clin Infect Dis 48:1285-92. 2009.
  6. Herbeck JT, Gottlieb GS, Li X, et al. Lack of evidence for changing virulence of HIV-1 in North America. PLoS One 3:e1525. 2008.
  7. Troude P. Chaix ML, Tran L, et al. No evidence of a change in HIV-1 virulence since 1996 in France. AIDS 23:1261-7. 2009.
  8. Aleman S, Soderbarg K, Visco-Comandini U, et al. Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy. AIDS. 16:1039-44. 2002.
  9. Boillat-Blanco N, Darling KE, Schoni-Affolter F, et al. Virological outcome and management of persistent low-level viraemia in HIV-1-infected patients: 11 years of the Swiss HIV Cohort Study. Antivir Ther. 2014.
  10. Antiretroviral Therapy Cohort Collaboration. Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients. AIDS 29:373-83. 2015.
  11. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents (米国DHHS、Feb 24, 2021). https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-arv/whats-new-guidelines
  12. NIH; https://www.nih.gov/news-events/news-releases/science-clear-hiv-undetectable-equals-untransmittable
  13. NIAIDS ; https://www.niaid.nih.gov/diseases-conditions/treatment-prevention
  14. Executive director of the Prevention Access Campaign Bruce Richman ; https://www.youtube.com/watch?v=PmBLCFDvmts
  15. Rodger AJ, Cambiano V, Bruun T, et al. ; PARTNER Study Group. Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy. JAMA. 2016 Jul 12;316(2):171-81.
  16. Bavinton BR, Pinto AN, Phanuphak N, et al. Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study. Lancet HIV. 2018 Aug;5(8):e438-e447.
  17. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117-22. 1995.
  18. Ho DD, Neumann AU, Perelson AS, et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-6. 1995.
  19. Siliciano JD, Kajdas J, Finzi D, et al. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat Med 9:727-8. 2003.

PAGE TOP

アンケートにご協力ください。

このページは役に立ちましたか?

コメント